Intestinal anti-inflammatory drug targets as potential modifiers of cardiovascular disease risk

doi: 10.1016/j.jpha.2025.101403

• Shuangshuang Tong^a , 
• Junjun Ye^a , 
• Yanlin Lyu^a , 
• Jiating Su^a , 
• Baoxin Yan^a , 
• Xianzhen Cai^a , 
• Barkat Ali Khan^b , 
• Muhammad Azhar Ud Din^c,d , 
• Kaijian Hou^{e,f ,}  , 
• Jilin Li^{a ,  ,} 

• a. Department of Cardiology, Second Affiliated Hospital of Shantou University Medical College, 515000 Shantou, Guangdong, China;

• b. Drug Delivery and Cosmetics Lab (DDCL), GCPS, Faculty of Pharmacy Gomal University D. I. Khan 29050, Pakistan;

• c. Department of Laboratory Medicine, the Affiliated People's Hospital, Jiangsu University, Zhenjiang 212002, Jiangsu, P. R. China;

• d. Institute of Hematology, Jiangsu University, Zhenjiang 212013, Jiangsu, P. R. China;

• e. Longhu People Hospital, Shantou 515000, Guangdong, China;

• f. School of Public Health, Shantou University, Shantou 515041, Guangdong, China